uvsW Antibody

What is UvsW protein and why are antibodies against it important in bacteriophage research?

UvsW is a multifunctional protein produced by bacteriophage T4 that participates in DNA repair, recombination, and replication. It functions as an RNA-DNA helicase that dissociates RNA from origin R-loops, serving as a molecular switch that allows T4 replication to transition from origin-dependent to recombination-dependent mechanisms . Antibodies against UvsW enable researchers to:

• Detect and quantify UvsW protein expression during infection cycles

• Study the temporal dynamics of UvsW activity in phage DNA metabolism

• Investigate protein-protein interactions involving UvsW

• Examine the spatial distribution of UvsW within infected cells

• Track the correlation between UvsW expression and changes in replication mode

These applications provide valuable insights into fundamental bacteriophage biology and broader principles of DNA replication regulation.

How can I validate the specificity of a commercial UvsW antibody before using it in my experiments?

Comprehensive antibody validation is essential for reliable experimental results. For UvsW antibodies, implement the following validation strategies:

• Genetic controls: Compare signal between wildtype T4-infected bacteria and those infected with a UvsW deletion mutant (such as uvsWΔ1)

• Western blot analysis: Confirm detection of a protein with the expected molecular weight (~59 kDa)

• Peptide competition assay: Pre-incubate the antibody with purified UvsW protein or peptide to block specific binding

• Temporal expression: Verify that the antibody detects UvsW with expression patterns consistent with its known late expression during T4 infection

• Cross-reactivity testing: Assess potential reactivity with related helicases or host proteins

• Multiple detection methods: Validate results using orthogonal techniques (e.g., mass spectrometry)

Following best practices in antibody validation will ensure specificity and reproducibility in your UvsW protein studies .

What sample preparation techniques are recommended when detecting UvsW protein in bacteriophage-infected cells?

Optimal sample preparation is critical for successful detection of UvsW protein:

• Timing of sample collection:

  • Collect samples at multiple time points (e.g., 5, 15, 30, and 45 minutes post-infection)

  • Include late infection timepoints when UvsW is normally synthesized

• Cell lysis methods:

  • For Western blotting: Sonicate infected cells in RIPA buffer with protease inhibitors

  • For immunoprecipitation: Use milder NP-40 based buffers to preserve protein interactions

  • For fractionation studies: Separate cytoplasmic and nucleoid-associated fractions

• Protein extraction from T4-infected bacteria:

  • Resuspend bacterial pellet in SDS-PAGE loading buffer

  • Boil for 5 minutes to ensure complete lysis

  • Centrifuge to remove insoluble material

  • For total nucleic acid isolation, digest with SspI to analyze phage DNA replication

• Storage considerations:

  • Flash-freeze samples in liquid nitrogen

  • Store at -80°C with protease inhibitors

  • Avoid repeated freeze-thaw cycles

These preparations will help ensure consistent and reliable detection of UvsW protein in your experiments.

What are the major applications of UvsW antibodies in DNA replication and repair studies?

UvsW antibodies enable several key experimental approaches in bacteriophage T4 research:

These applications allow researchers to dissect the mechanisms by which UvsW contributes to the transition from origin-dependent to recombination-dependent replication during T4 infection .

How do I interpret Western blot results when comparing wildtype UvsW versus the K141R mutant?

The K141R mutation in the Walker A motif eliminates both ATPase and helicase activities of UvsW . When comparing Western blots of wildtype versus mutant protein:

• Expression levels: Both proteins should be expressed at similar levels if under the same promoter, but differences may indicate stability issues

• Molecular weight: The mutation should not significantly alter the apparent molecular weight (~59 kDa)

• Post-translational modifications: Look for differences in banding patterns that might indicate altered modifications

• Timing of expression: Both should follow similar temporal patterns if expressed from native promoters

• Protein stability: The K141R mutant may show altered stability compared to wildtype

Interpretation example:

• In wildtype T4 infection, UvsW protein appears at late times and correlates with the disappearance of origin replication intermediates

• In K141R mutant infection, the protein appears at similar times but origin replication intermediates persist longer, indicating functional deficiency

• In uvsY- background, the K141R mutation can suppress the DNA arrest phenotype similar to a complete UvsW knockout (uvsWΔ1)

These comparisons provide insights into how the ATPase/helicase activity of UvsW contributes to its biological functions.

How can UvsW antibodies be used to study the transition from origin-dependent to recombination-dependent replication?

UvsW antibodies provide powerful tools for investigating this critical replication mode switch:

• Temporal correlation studies:

  • Use Western blotting with UvsW antibodies to track protein accumulation

  • Simultaneously analyze replication intermediates using two-dimensional gel electrophoresis

  • Document the correlation between UvsW expression and disappearance of origin-specific replicative intermediates at ori(uvsY) and ori(34)

• Chromatin immunoprecipitation approaches:

  • Perform ChIP with UvsW antibodies at different infection stages

  • Analyze the changing association of UvsW with origins versus recombination sites

  • Map the temporal transition of UvsW binding across the T4 genome

• Replication intermediate analysis:

  • Use two-dimensional gel analysis to track replicative intermediates at ori(uvsY)

  • Compare persistence of these intermediates between wildtype and uvsW mutant infections

  • Observe how early artificial expression of UvsW affects these intermediates

• Functional reconstitution:

  • Develop in vitro systems with purified components

  • Use UvsW antibodies to selectively inhibit or deplete the protein

  • Monitor the effect on R-loop stability and replication initiation

These approaches reveal how UvsW functions as a molecular switch that allows T4 replication to progress from origin-dependent to recombination-dependent modes .

What technical considerations are important when using UvsW antibodies to investigate R-loop processing in vitro?

When studying R-loop processing with UvsW antibodies, several technical factors must be addressed:

• R-loop substrate preparation:

  • Generate synthetic R-loops mimicking natural T4 origins

  • Include ori(uvsY) and ori(34) structures for physiological relevance

  • Label RNA and/or DNA strands with fluorophores or radioisotopes

• Purified protein considerations:

  • Compare wildtype UvsW with the K141R mutant as a negative control

  • Ensure removal of tags that might interfere with activity

  • Verify protein quality using SDS-PAGE and activity assays

• Reaction conditions optimization:

  • ATP concentration (typically 1-5 mM)

  • Magnesium concentration (2-10 mM)

  • Salt concentration (50-150 mM NaCl)

  • Temperature (usually 30-37°C)

  • pH (typically 7.5-8.0)

• Antibody effects assessment:

  • Test whether antibody binding affects helicase activity

  • Compare activity with antibody Fab fragments versus full IgG

  • Include appropriate controls (non-specific IgG, pre-immune serum)

• Data analysis parameters:

  • Initial rates versus endpoint measurements

  • Quantification of unwound versus intact R-loops

  • Statistical analysis of replicate experiments

These considerations ensure robust and reproducible investigation of UvsW's R-loop processing activity.

How might UvsW antibodies be used to distinguish between origin R-loops and other R-loop structures in T4-infected cells?

Distinguishing between different R-loop populations requires sophisticated antibody-based approaches:

• Sequential immunoprecipitation:

  • First IP: Use S9.6 antibody (recognizes all RNA:DNA hybrids)

  • Second IP: Use UvsW antibodies to identify UvsW-associated R-loops

  • This approach identifies the subset of total R-loops bound by UvsW

• Proximity ligation assays:

  • Combine UvsW antibodies with antibodies against origin-binding proteins

  • A positive signal indicates R-loops that are specifically associated with origins

  • Compare with signals from antibodies against transcription factors

• ChIP-seq correlation analysis:

  • Perform parallel ChIP-seq with UvsW antibodies and S9.6 antibodies

  • Bioinformatic comparison identifies overlapping and distinct R-loop populations

  • Integrate with transcriptome data to distinguish transcription-associated R-loops

• Temporal dynamics analysis:

  • Track UvsW association with R-loops across infection timeline

  • Origin R-loops should show different temporal patterns than transcription-associated R-loops

  • Early infection samples will enrich for origin R-loops before UvsW expression

• Genetic background comparison:

  • Compare R-loop profiles between wildtype and UvsW-K141R mutant infections

  • Origin R-loops should persist longer in the K141R background

  • Transcription-associated R-loops may show different dependency patterns

These approaches allow researchers to specifically characterize the origin R-loops that serve as substrates for UvsW helicase activity during the replication mode switch.

What approaches can be used to develop antibodies that specifically recognize the ATP-bound form of UvsW protein?

Developing conformation-specific antibodies for the ATP-bound UvsW requires specialized strategies:

• Structure-guided immunization:

  • Generate UvsW protein locked in the ATP-bound state using non-hydrolyzable ATP analogs (AMP-PNP)

  • Stabilize this conformation through chemical cross-linking

  • Use computational analysis to identify unique epitopes in this conformation

• Phage display selection with biophysics-informed model:

  • Perform alternating positive selection against ATP-bound UvsW and negative selection against apo-UvsW

  • Utilize computational models to identify antibodies targeting specific binding modes

  • Apply machine learning to optimize selection of specificity-conferring sequences

• Validation strategies:

  • Develop a panel of binding assays under various nucleotide conditions

  • Compare binding to wildtype versus K141R mutant (which should retain ATP binding but not hydrolysis)

  • Use structural studies (hydrogen-deuterium exchange, cryo-EM) to confirm epitope accessibility

• Specificity engineering:

  • Perform affinity maturation focusing on discriminating residues

  • Engineer antibodies with enhanced specificity for the ATP-bound conformation

  • Test specificity across related helicases with similar ATP-binding domains

These conformation-specific antibodies would provide valuable tools for tracking the active form of UvsW during infection and replication processes.

How can ChIP-seq with UvsW antibodies contribute to understanding genome-wide R-loop dynamics during phage infection?

ChIP-seq with UvsW antibodies offers powerful insights into R-loop biology during T4 infection:

• Experimental design considerations:

  • Sample multiple timepoints post-infection (early, middle, late phases)

  • Include parallel infections with wildtype and K141R mutant phage

  • Perform matched RNA-seq and DNA-seq for comprehensive analysis

• ChIP-seq optimization for bacterial systems:

  • Cross-link infected E. coli at appropriate timepoints

  • Optimize sonication for bacterial cells (typically more challenging than eukaryotic cells)

  • Use highly specific UvsW antibodies validated for IP applications

  • Include appropriate controls (input DNA, non-specific IgG IP)

• Integrated data analysis approaches:

  • Map binding patterns of UvsW across the T4 genome

  • Identify dynamic changes in binding sites over the infection cycle

  • Correlate UvsW occupancy with known origins and transcriptionally active regions

  • Compare profiles between wildtype and K141R mutant infections

• Expected findings and interpretations:

• Functional validation:

  • Select candidate regions for detailed biochemical analysis

  • Reconstruct R-loops in vitro from sequences identified in ChIP-seq

  • Test UvsW activity on these substrates using purified components

This genome-wide approach would provide unprecedented insights into the complete spectrum of UvsW activities during phage infection and reveal potential new functions beyond origin R-loop processing.